OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Retinal and Eye Research is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Widefield OCT angiography	234
In vivo application of base and prime editing to treat inherited retinal diseases	233
The neuroimmune interface in retinal regeneration	233
Cell identity changes in ocular surface Epithelia	143
Animal models for the evaluation of retinal stem cell therapies	138
Immunological aspects of RPE cell transplantation	121
Non-vasogenic cystoid maculopathies	120
Editorial Board	98
Unravelling CYP4V2: Clinical features, genetic insights, pathogenic mechanisms and therapeutic strategies in Bietti crystalline corneoretinal dystrophy	97
Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration	96
Corneal stromal repair and regeneration	94
Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives	93
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas	92
Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens	88
Central serous chorioretinopathy: An evidence-based treatment guideline	88
Editorial Board	87
Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors	87
Squishy matters – Corneal mechanobiology in health and disease	80
Photocoagulation for retinal vein occlusion	78
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)	78
Homeostatic plasticity in the retina	72
A paradigm shift in retinal detachment repair: The concept of integrity	71
Myocilin misfolding and glaucoma: A 20-year update	70
The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease	70
Risk factors, clinical features and treatment of Behçet's disease uveitis	70

Cell fate decisions, transcription factors and signaling during early retinal development	66
Editorial Board	66
Protection against corneal hyperosmolarity with soft-contact-lens wear	64
The retinal pigmentation pathway in human albinism: Not so black and white	63
Genetic architecture of congenital cataracts: correlation of pathogenic variants with morphology and clinical outcomes	63
Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration	63
How gut microbiota may impact ocular surface homeostasis and related disorders	61
RNA-targeting strategies as a platform for ocular gene therapy	61
Corrigendum to “Optical coherence tomography in the management of diabetic macular oedema” [Prog. Retin. Eye Res. 98 (2024) 101220]	61
Approaches for corneal endothelium regenerative medicine	61
Cellular component transfer between photoreceptor cells of the retina	60
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy	59
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence	57
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives	57
Rhodopsin, light-sensor of vision	56
Optical coherence tomography angiography in diabetic retinopathy	56
Editorial Board	55
Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapies	54
Retinal pigment epithelium 65 kDa protein (RPE65): An update	53
Regulation of lens water content: Effects on the physiological optics of the lens	53
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye	53
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation	53
The march to harmonized imaging standards for retinal imaging	52
The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems	52
Quantitative approaches in multimodal fundus imaging: State of the art and future perspectives	50
Retinal TRP channels: Cell-type-specific regulators of retinal homeostasis and multimodal integration	50
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)	47
Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity	43
VEGFR1 signaling in retinal angiogenesis and microinflammation	43
Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma	43
Bacterial keratitis: identifying the areas of clinical uncertainty	43
The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies	42
Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases	41
The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health	41